Zdrowie i gospodarka · 27/03/2007

FDA Releases Draft Guidance on Premarket Approval for Class III Devices

The Food and Drug Administration (FDA) has published a draft guidance to assist the regulated industry in determining whether a Premarket Approval (PMA) supplement or notification is required for class III devices subject to PMA, as part of the PMA supplement decision-making process.